Novartis invests €104M to expand Ivrea radiopharmaceutical plant in Italy

Novartis inaugurated a new 3,000-square-meter facility at its Ivrea site in Colleretto Giacosa, Italy, with an investment of €84 million over three years to boost production of radioligand therapies for prostate cancer. An additional €20 million was allocated for a new building for diagnostic products and R&D.

“Novartis investe in Piemonte e rafforza la sua presenza sul territorio con l’ampliamento del polo di Ivrea, fiore all’occhiello per l’Italia nell’innovazione oncologica.”sanitainformazione.it

• 1 source
• sanitainformazione.itNovartis investe in Piemonte: oltre 100 mln di euro per ampliare il polo di Ivrea | Sanità InformazioneMarco LanducciOct 20, 2023

Summarized from public sources; check the original articles before acting on it.